Stay updated on Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. This appears to be a backend/UI version bump that does not modify the study content or how users interact with the page.SummaryDifference0.0%

- Check40 days agoChange DetectedFooter revision updated from v3.4.0 to v3.4.1, with no changes to study details or page navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check61 days agoChange DetectedMinor page revision: version updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedIntroduced a Locations section with Minnesota as a study site and removed the older Minnesota Locations entry and the HHS Vulnerability Disclosure link; page updated to revision v3.3.3.SummaryDifference0.2%

- Check112 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2; no changes to study content or page functionality were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page.